Biovision presents its selection of 44 promising life sciences businesses and projects
Biovision, the annual forum on future-oriented research in life sciences, today announces the list of biotech and medtech companies and projects selected for the Investor Conference and Catalyzer sessions. Awards will be presented during the closing ceremony. Co-organized with France Biotech and Lyonbiopole, the Investor Conference brings together start-ups, growth companies and mid-sized businesses with financial and industry partners for a series of discussions and meetings. The 24 innovative businesses were selected from 65 applicants by a committee chaired by Alexia Perouse (of Omnes Capital, France) and Tim Haines (Abingworth, UK) and including Europe's key private investors.